It is a smart strategy to diversify your portfolio by investing in high-quality companies built on proven technologies.

Pairwise has licensed its Fulcrum® gene editing platform to the International Rice Research Institute (IRRI), a non-profit agricultural research organization. The agreement will enable IRRI to apply ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is a natural defense system in bacteria that scientists have adapted into a powerful gene-editing tool. This ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

This California high school features multi-hour labs that blend topics and the curriculum is tailored to students’ interests.

[MEXICO CITY, SciDev.Net] Researchers in Mexico are urging the government to develop clear regulations that distinguish gene-editing technologies, such as CRISPR, from genetically modified organisms ...

Speaking at the All-In Summit 2025 in September, Wood highlighted healthcare as "the most profound application of AI," reported Business Insider. She said combining artificial intelligence with ...